Reports and Data

Peptide Therapeutics Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2027

 

New York, NY -- (SBWIRE) -- 02/01/2021 -- Peptides are the combination of two or more amino acid monomers linked by amide bonds. Researchers have demonstrated that peptides are distinguished from protein on the basis of size. Peptide therapeutics have applications in several indications such as cancer, central nervous system disorders, respiratory disorders, and cardiovascular diseases; this is due to the high selectivity, efficacy, and safety of peptides. The Global Peptide Therapeutics market was valued at USD 27.63 Billion in 2019 and is expected to reach USD 55.15 Billion by the year 2027, at a CAGR of 9.0%.

Get a Sample Report PDF with Detail TOC & List of Figures @ https://www.reportsanddata.com/sample-enquiry-form/2770

Leading Players Profiled in the Report Include:

Sanofi (Australia), Teva Inc (Israel), Novo Nordisk Inc, (Denmark), Takeda (Japan), Eli Lily (United States), Astra Zeneca (U.K.), Novartis (Switzerland), Shire (U.S.) Abbvie (U.S.), Ipsen (France) Allergen (Ireland ), Ferring (Switzerland), Merck (United States), The Medicines (United States), Roche (Switzerland) Johnson and Johnson (United States).

Market Drivers

The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. Growing research and development activities along with a rich peptide therapeutics pipeline are expected to fuel the growth of the peptide therapeutics market. New technological advancements and new peptide developments by the pharmaceutical companies are propelling the demand for cost-effective peptide therapeutics, which, in turn, is the key factor driving the market size of the peptide therapeutics market.

Regional Landscape 

North America will be leading the global peptide therapeutics market in the coming years due to the high prevalence of chronic diseases, high healthcare expenditure, and high research and development activities. Asia Pacific is the fastest-growing region in the global peptide therapeutics market. The key factor driving the growth of the global peptides market in the region is the increasing demand for healthcare expenditure, etc., in emerging economies like China and India.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/2770

For the purpose of this report, Reports and Data has segmented the Peptide Therapeutics       market based on Route of Administration, Product Type, Type of Manufacturers, Application, Synthesis, Regional Outlook:

Route of Administration (Revenue in Million USD; 2016–2026)

Parenteral Route
Oral Route
Pulmonary
Mucosal
Others

Product Type Outlook (Revenue in Million USD; 2016–2026)

Generic
Innovative

Type of Manufacturers (Revenue in Million USD; 2016–2026)

In-house
Outsourced

Application Outlook (Revenue in Million USD; 2016–2026)

Cancers
Metabolic
Cardiovascular Disorder
Respiratory
GIT
Anti-infection
Pain
Dermatology
CNS
Renal
Others

Synthesis Outlook (Revenue in Million USD; 2016–2026)          

Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

Regional Outlook (Revenue in Million USD; 2016–2026)

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Browse Complete Report "Peptide Therapeutics Market" @ https://www.reportsanddata.com/report-detail/peptide-therapeutics-market

Table of contents

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2016 – 2026

Chapter 3. Indicative Metrics

    3.1. Macro-Economic Indicators

          3.1.1. Increased incidence of cancer, metabolic and cardiovascular diseases.

          3.1.2. The need for peptide conjugates.

          3.1.3. Increased investment for Research and Development activities in development of drug related to oncology.

Chapter 4. Global Peptide Therapeutics Segmentation & Impact Analysis

    4.1. Global Peptide Therapeutics Segmentation Analysis

    4.2. Industrial Outlook

    4.3. Market Indicators Analysis

         4.3.1. Market Drivers Analysis

Continued…..

Read More Reports:-

Encryption Software Market Drivers

Antimicrobial Coatings Market Manufacturers

Spinal Trauma Devices Market Revenue

Thermal Spray Coatings Market Segments

Carbon Felt and Graphite Felt Market Overview

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.